Chief Commercial Officer, Sky Medical Technology
Andrew Thelwell is Chief Commercial Officer of Sky Medical Technology, a UK MedTech company founded in 2007. Sky Medical has created a platform technology to address a range of medical conditions including the prevention of life threatening blood clots, complications related to swelling after orthopaedic and trauma-based surgery, and hard-to-heal chronic wounds healing (leg ulcers). The company’s breakthrough technology is embedded in its wearable medical therapy – the geko™ device. The watch-sized device, worn at the knee, elicits lower limb muscle activation via gentle electrical nerve stimulation, compressing the deep veins of the calf to increase blood flow. Andrew and the team at Sky partner with medical professionals around the world to transform how healthcare is delivered.
Andrew has over 30 years’ experience within medical devices and biotechnology, across a broad range of sales, marketing and commercial roles. Within the biotech area his most recent role was Director of European Commercial Operations, but the bulk of his career has been spent in medical devices, initially at Smith and Nephew and then with ConvaTec. At Sky Medical Technology he is responsible for all aspects of the commercial development of the company.